Learning Objectives:

  1. To describe the effect of APOE genotype on risk for Alzheimer’s disease;
  2. To describe the effect of APOE and TREM2 on amyloid related pathologies;
  3. To describe the effect of APOE and TREM2 on tau pathology and tau-mediated neurodegeneration
Session date: 
Thursday, March 18, 2021 - 7:30am to 8:30am
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. David Holtzman, MD